Vsn Laboratories Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
as on 04-07-2024
- Paid Up Capital ₹ 7.50 Cr
as on 04-07-2024
- Company Age 15 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 22.60 Cr
as on 04-07-2024
- Revenue -7.32%
(FY 2023)
- Profit -74.81%
(FY 2023)
- Ebitda -52.50%
(FY 2023)
- Net Worth 0.51%
(FY 2023)
- Total Assets -2.36%
(FY 2023)
About Vsn Laboratories
The Corporate was formerly known as Lucid Life Sciences Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 7.50 Cr.
The company currently has active open charges totaling ₹22.60 Cr.
Vemula Padmavathi, Madhusudhan Konda, and Indira Konda serve as directors at the Company.
- CIN/LLPIN
U24100TG2009PTC063841
- Company No.
063841
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jun 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Vsn Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhusudhan Konda  | Managing Director | 18-Aug-2017 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vemula Padmavathi | Director | 24-Dec-2009 | Current |
| Indira Konda | Director | 18-Aug-2017 | Current |
Financial Performance of Vsn Laboratories.
Vsn Laboratories Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.32% decrease. The company also saw a substantial fall in profitability, with a 74.81% decrease in profit. The company's net worth moved up by a moderate rise of 0.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vsn Laboratories?
In 2021, Vsn Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mithvassaa Ventures Private LimitedActive 19 years 1 monthMadhusudhan Konda and Indira Konda are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Jan 2015 | ₹22.60 Cr | Open |
How Many Employees Work at Vsn Laboratories?
Vsn Laboratories has a workforce of 22 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vsn Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vsn Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
